Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study

Launched by AZIENDA USL REGGIO EMILIA - IRCCS · May 20, 2025

Keywords

ClinConnect Summary

This clinical trial is looking into how employers in Italy view the process of helping employees who have been diagnosed with cancer return to work. The study aims to understand the experiences and opinions of employers who have had to manage this sensitive situation. By gathering insights from these employers, the researchers hope to improve support for cancer survivors as they reintegrate into the workplace.

To participate in this study, employers must work for a company and have been involved in the return-to-work process for at least one employee with a cancer diagnosis in the past five years. This could include roles like line managers or human resource managers. The trial is not yet recruiting participants, but it seeks to shed light on how employers can better support their employees during and after cancer treatment, which is essential for a smoother transition back to work.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. employers\* of a company
• • 2. being directly involved in managing the RTW process of at least one employee with cancer diagnosis in the last 5 years.
• • An employer can be the specific person who represents the company where the employee was working at the time of cancer diagnosis or a person who supported the employee during the sickness absence and the RTW process (e.g., line manager, human resource manager).
• Exclusion Criteria:
• • none